-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Amir Tafesh, MD1*, Dana Yehudai-Ofir, MD2,3*, Ofrat Beyar-Katz, MD, PhD2,4*, Hazim Khatib, MD3*, Baher Krayem, MD3*, Avraham Frisch, MD3*, Tsila Zuckerman, MD2,5 and Israel Henig, MD3*

1Division of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel
2Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
4Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
5Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Moshav Ein Ayalla, Israel

Regis Peffault de Latour1,2*, Edouard Forcade, MD, PhD3*, Anne Huynh, MD4*, Mathieu Leclerc, MD, PhD5*, Stéphanie Nguyen Quoc, MD, PhD6*, Patrice Ceballos, MD7*, Jean-Baptiste Méar, MD8*, Michael Loschi, MD, PhD9*, Helene Labussiere-vallet, MD10*, Jean-Henri Bourhis, MD, PhD11, Bruno Lioure12*, Ibrahim Yakoub-Agha, MD, PhD13*, Jacques-Olivier Bay, MD, PhD14*, Sylvie François, MD15*, Claude-Éric Bulabois, MD16*, Sylvain Chantepie, MD17*, Marie-Thérèse Rubio, MD, PhD18*, Patrice Chevallier, MD, PhD19,20, Anne Lise Mesnard21*, Delphine Lebon22*, Jean Valere Malfuson23*, Jérôme Cornillon24*, Etienne Daguindau, MD25*, Pascal Turlure, MD26*, Natacha Maillard, MD27*, Alban Villate, MD28*, Marie Robin, MD29*, Nicole Raus, RN30*, Jean-Yves Cahn, MD31*, Arnaud Pigneux, MD, PhD32*, Mathilde Hunault, MD33*, Christian Recher, MD, PhD34*, Hervé Dombret, MD, PhD35,36,37, Gerard Socie38, Jean François Hamel, MD39* and Raynier Devillier, MD, PhD40*

1Hematology and Transplantation Unit, Hôpital Saint Louis, AP-HP, Paris, France
2Université Paris Cité, Paris, France
3Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
4Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
5Hematology Department, Henri Mondor University Hospital, AP-HP, Créteil, France
6Hematology Department, Sorbonne Université, Hôpital Pitié-Salpêtrière, APHP, Paris, France
7Clinical Hematology Department, Montpellier University Hospital, Saint Eloi Hospital, MONTPELLIER, France
8BMT unit, CHU Rennes, Rennes, France
9Hematology Department, Nice University Hospital, Nice, France
10BMT unit, CHU Lyon, Lyon, France
11BMT Service, Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
12Hematology, Department of Hematology, University Hospital of Strasbourg Institut De Canc, Strasbourg, France
13Lille University Hospital, Lille, France
14CHU ESTAING, Clermont-Ferrand, France
15Hematology Department, Angers University Hospital, Angers, France
16Hematology Department, Grenoble University Hospital, Grenoble, France
17Basse-Normandie Institute of Hematology, CHU de Caen, Caen, France
18Department of Hematology, Nancy University Hospital, Vandoeuvre Les Nancy, France
19Hematology Department, Nantes University Hospital, Nantes, France
20Hematology Clinic, Nantes University Hospital, Nantes, France
21BMT unit, CHU Rouen, Rouen, France
22Université Picardie Jules Verne, Amiens, FRA
23Centre des armées Percy, CLAMART CEDEX, FRA
24Département d'hématologie Clinique et de Thérapie Cellulaire, CHU Saint-Etienne, Saint-Etienne, France
25Department of Clinical Hematology, Hopital Jean Minjoz, Service d'Onco-hématologie, Besançon, France
26Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
27Hematology Department, CHU de Poitiers, Poitiers, France
28Hematology Department, Tours University Hospital, Tours, FRA
29Hopital Saint Louis, APHP, Paris, France
30SFGM-TC coordination, Hôpital Lyon Sud, Lyon, FRA
31Hematology Department, CHU Grenoble, Grenoble, France
32Department of Clinical Hematology, Haut-Lévèque Hospital, CHU Bordeaux, Pessac, France
33HOTEL DIEU, ANGERS CEDEX 9, FRA
34ICUT oncopole, Toulouse, FRA
35Department of Clinical Hematology, Saint Louis University Hospital, Université Paris Cité-AP-HP, Paris, France
36Department of Hematology, Saint Louis University Hospital, AP-HP, Paris, France
37EA-3518, Saint Louis Research Institute, Université Paris Cité, Paris, France
38Hematology Transplantation, Paris, France
39Statistic, CHU Angers, Angers, France
40Hematology and Transplantation, Institut Paoli-Calmettes, Aix Marseille University, Marseille, France

Eleni Gavriilaki, MD, PhD1,2, Despina Mallouri, MD3,4*, Grigorios Salvaras, MD1*, Panagiotis Dolgyras, MD5*, Christos Demosthenous, MD1*, Ioannis Batsis, MD5*, Anna Vardi, MD1*, Ioannis Papadopoulos, MD1*, Zoi Bousiou, MD5*, Georgios Karavalakis, MD1*, Christos Varelas, MD1*, Alkistis Kyra Panteliadou, MD1*, Nikolaos Spyridis, MD1*, Antonia Syrigou, MD1*, Anastasia Marvaki, MD1*, Maria Papathanasiou, MD1*, Apostolia Papalexandri, MD1*, Chrysavgi Lalayanni, MD1*, Chrysanthi Vadikoliou, MD1*, Anastasia Athanasiadou, MD1*, Evangelia Yannaki, MD1* and Ioanna Sakellari, MD1*

1Hematology Department – BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece
2Aristotle University of Thessaloniki, Thessaloniki, Greece
3German Oncology Center, Hematology Department, Limassol, Cyprus
4German Oncology Center, Limassol, Cyprus, Thessaloniki, Greece
5Hematology Department – BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece

Jotaro Yamamoto1*, Hisashi Yamamoto, MD, PhD2*, Mika Kuno, MD2*, Otoya Watanabe, MD2*, Kyosuke Yamaguchi, MD3*, Kosei Kageyama, MD3*, Daisuke Kaji, MD, PhD2*, Yuki Taya, MD, PhD2*, Aya Nishida, MD2*, Shinsuke Takagi, MD, PhD2*, Kazuya Ishiwata, MD3*, Go Yamamoto, MD, PhD2*, Yuki Asano-Mori, MD4, Atsushi Wake, MD, PhD3 and Naoyuki Uchida2

1Department of Hematology, Toranomon Hospital, Minato City, Japan
2Department of Hematology, Toranomon Hospital, Tokyo, Japan
3Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan
4Department of Transfusion and Cell Therapy, Toranomon Hospital, Tokyo, Japan

Senlin Zhang1*, Qi Ji2* and Shaoyan Hu, MD, PhD2

1Children's Hospital of Soochow University, Suzhou, Suzhou, China
2Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Andrius Zucenka, MD1,2, Lukas Kevličius, MD1,2*, Tautvilė Smalinskaitė, MD1,2*, Guoda Daukėlaitė, MD1,2*, Linas Davainis, MD1*, Igoris Trociukas, MD1*, Artūras Slobinas, MD1,2*, Renata Jucaitienė, MD1*, Inga Šlepikienė, MD1*, Rita Čekauskienė, MD1,2*, Vaida Jaraminė1*, Justė Strumskytė1*, Artūras Jakubauskas, PhD1* and Laimonas Griškevičius, MD, PhD1,2*

1Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
2Hematology and Oncology Department, Faculty of Medicine, Vilnius University, Vilnius, Lithuania

Andrew D. Trunk, MD1, Hong Li, PhD2*, Matt Kalaycio, MD3, Ronald Sobecks, MD4, Claudio Brunstein, MD, PhD5, Craig S. Sauter, MD5 and Betty K. Hamilton, MD6

1Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Shaker Heights, OH
2Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic, Cleveland
3Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Blood and Marrow Transplant, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Cleveland Clinic Foundation, Cleveland, OH

Carl E Allen, MD1, Shanmuganathan Chandrakasan, MD2, Michael B. Jordan, MD3, Jennifer W Leiding, MD4*, Michael Marrone, PhD5*, Abiola Oladapo6*, Priti Pednekar, PhD7*, Kelly J. Walkovich, MD8 and John Yee, MD6*

1Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX
2Aflac Cancer and Blood Disorder Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Decatur, GA
3Divisions of Immunobiology, and Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
4Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD
5Sobi Inc., Waltham, MA
6Sobi, Inc., Waltham, MA
7PRECISIONheor, Bethesda, MD
8University of Michigan, Ann Arbor, MI

Margaret L. MacMillan, MD, MSc, FRCPC1, Qing Cao, MSc2*, Martin Felices, PhD3*, Megan Larson4*, David McKenna, MD5, Meera Srikanthan, MD1 and John E Wagner, MD4

1Blood and Marrow Transplantation & Cellular Therapy Program, University of Minnesota, Minneapolis, MN
2Biostatistics and Informatics, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN
3Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
4University of Minnesota, Minneapolis, MN
5Univ. of Minnesota Clinical Cell Therapy Lab., Molecular & Cellular Therapeutics, Saint Paul, MN

Lucia Bolea1*, Alejandro Luna, MD, PhD1*, Enrique Blanco1*, Valentín García Gutiérrez Sr.2, Anabelle Chinea, PhD1*, Begoña Hijono1*, Maria Luisa Palacios-Berraquero3*, Pablo Palomo Rumschisky, MD2*, Blanca De Felipe1*, Lucía Pérez-Lamas4*, Carlos Jiménez, MD5, Beatriz Astibia Mahillo, MD1*, Alejandro Zurdo-Castronuño1*, Maria Piñero1*, Rut Corrales1*, Pilar Herrera1* and Javier López2*

1Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
2Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
3Hospital Universitario 12 de Octubre, Madrid, Spain
4Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
5Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Zhijie Wei1,2*, Fei Pan1*, Jing Long, MD1*, Guanlan Yue2*, Kang Gao2*, Kun Wang2*, Huili Zhu2*, Yujie Wang2*, Zheren Wang2* and Peihua Lu, MD1,2,3

1Beijing Lu Daopei Hospital, Beijing, China
2Hebei Yanda Lu Daopei Hospital, Langfang, China
3Beijing Lu Daopei Institute of Hematology, Beijing, China

Wei Cui*, Xiaoqian Chen*, Qingya Cui*, Zheng Li, MD*, Sifan Chen*, Mengyun Li*, Xuekai Li*, Juan Chen*, Yan Yu*, Depei Wu, MD, PhD and Xiaowen Tang*

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Huizhu Kang, MD1,2*, Yuejun Liu, MD, PhD1,2*, Ruju Wang, MD1,2*, Meng Zhou, MD, PhD1,2*, Chengyuan Gu, MD1,2*, Xuefeng He, MD, PhD1,2*, Jun Chen3*, Zhihong Lin3*, Depei Wu, MD, PhD1,2 and Yue Han, MD, PhD1,2*

1Hematology, The First Affiliated Hospital of Soochow University, National clinical research center for hematologic diseases, Institute of Blood and Marrow Transplantation, Suzhou, China
2Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China
3Suzhou Yongding Hospital, Suzhou, China

Mohammad Tarek, MD, MSc1,2*, Adham Gamal, MBBCh1*, Mohamed Eissa, MBBCh1*, Hazem Kraitem, MBBCh1*, Nader Abdelaziz, MBBCh1*, Mohamed Fathy, MBBCh1*, Hesham Shaban, MBBCh1*, Abdulrahman Habashy, MSc1,2*, Ahmed Ismael, MSc1*, Khaled Zakareya, MSc1*, Essam Eldin Khater, MSc1*, Omar Abou El-Hasan, MSc1*, Moheb Tharwat, MSc1*, Mohamed El-Safty, MSc1*, Islam Elzaeem, MSc1*, Islam Abdelwahed, MSc1*, Mohamed Elprince, MSc1*, Ahmed El-Husseiny, MSc1*, Mohamed Negm, MSc1*, Ahmed Kasbar, MD1*, Hussein Hammam, MD1*, Sameh Emara, MD1*, AbdelSalaam Atallah, MD1*, Marwa Salah, MD2*, Sara Abdelghany, MD2*, Maha Farouk, MD2*, Hala Fahmy, MD2*, Noha El Husseiny, MD2*, Sherif Mahmoud, MD1*, Mohamed Roshdy, MD2*, Mervat Mattar, MD2*, George Baheig, MD1* and Mohamed Hamed Khalaf, MD1*

1Clinical Hematology and Bone Marrow Transplantation Department, Oncology & Hematology Hospital, Maady Military Medical Compound., Cairo, Egypt
2Clinical Hematology Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt

Samar Kulkarni, MD FRCP FRCPath1*, Adrian Bloor, Phd FRCP FRCPath1*, Mike Dennis, MD, MRCP, FRCPath1, Anna Z Castleton1*, Mark Williams, PhD MRCP FRCPath1*, Ahmed Abdulgawad, MSc, PhD, MRCP, FRCPath1*, Tim Somervaille, PhD FRCP FRCPath1, Daniel H Wiseman, MB ChB PhD MRCP FRCPath1*, Vismay Deshani2*, Emma Searle, MD, PhD1*, Angie Leather, MSc1*, John Murray, MSc1*, Sally Pickering, MSc1* and James Cavet, PhD FRCP FRCPath1*

1The Christie NHS Foundation Trust, Manchester, United Kingdom
2The Christie NHS Foundation Trust, Manchester, ENG, United Kingdom

Martin Schmidt-Hieber1*, Per T. Ljungman, MD, PhD2, Patrick Gilbert3*, Nina Knelange3*, Joanna Drozd-Sokolowska4*, Grzegorz Basak5*, Hermann Einsele, MD6, Gloria Tridello3*, Nour Ben Abdeljelil, MD7*, Alexander Kulagin, MD, PhD8*, Aitana Balaguer Rosello, MD, PhD9*, Elisabetta Metafuni10*, Maura Faraci, MD11*, Jolanta Gozdzik, MD, PhD12*, Rodrigo Martino, MD13*, Anna Maria Raiola14*, Regis Peffault De Latour15*, Baris Kuskonmaz16*, Alessandra Biffi, MD, PhD17*, Krzysztof Czyzewski18*, Melissa Ann Gabriel, BMBS19, Joaquín Martínez-Lopez20*, Malgorzata Mikulska21*, Zinaida Peric22*, Dina Averbuch, MD23*, Jan Styczynski, MD, PhD24* and Rafael De La Camara, MD25

1Medical University Lausitz - Carl Thiem (MUL-CT), Cottbus, Germany
2Karolinska University Hospital, Stockholm, SWE
3EBMT Leiden Study Unit, Leiden, Netherlands
4Warszawski Uniwersytet Medyczny, Warsaw, POL
5KATEDRA I KLINIKA HEMATOLOGII, TRANSPLANTOLOGII I CHORÓB WEWNĘTRZNYCH WYDZIAŁ LEKARSKI, Warsaw, AL, POL
6Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
7Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia
8RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
9Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
10Hematology Unit, Università Cattolica Del Sacro Cuore, Rome, ITA
11HSCT Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
12School of Medicine Jagiellonian University, Cracow, POL
13Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
14IRCCS Ospedale Policlinico San Martino, Genova, Italy, Genova, Italy
15BMT unit, Hôpital Saint-Louis,, Paris, France
16Department of Pediatric Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey
17Padua University Hospital, Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padova, Italy
18Pediatric hematooncology and Clinical transplantology Department of Pediatric Hematology and Oncology Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun Ul. M., Bydgoszcz, Poland
19Children's Hospital Westmead, Sydney, NSW, AUS
20Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Madrid, Spain
21University of Genova (Department of Health Sciences, DISSAL), Genova, Italy
22Department of Hematology, University Hospital Centre Zagreb, Zagreb, Croatia
23Faculty of Medicine, Hebrew University of Jerusalem, Hadassah Medical Center, Jerusalem, ISR
24Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, POL
25Hospital La Zarzuela, Madrid, ESP

Natalie Grier Smith, BA1,2*, Warren B. Fingrut, MD2,3*, Nicholas Waters, PhD4*, Katarina Piasevoli1*, Teng Fei, PhD5*, John Slingerland1*, Jonathan U. Peled, MD, PhD2,6 and Doris M. Ponce, MD, MS2,6,7

1Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
2Equal Contribution, New York, NY
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
6Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Weill Cornell Medical College, New York, NY

Marygrace S Duggar1*, Davide Leardini2*, Edoardo Muratore, MD3*, Akshay Sharma, MBBS4, Riccardo Masetti, MD, PhD5* and Ellie S Margolis, M.D., Ph.D.1*

1Infectious Disease, St. Jude Children's Research Hospital, Memphis, TN
2Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
3Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, AL, ITA
4Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
5Pediatric Hematology-Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Isabel H. Gonzalez-Bocco, MD1,2,3*, Haesook T. Kim, PhD4, Kaiwen Chen5*, Esther Arbona-Haddad, MD1,6*, Muneerah Aleissa, PharmaD, MPH7*, Kaitlyn M. Timblin8*, Jose Orejas, MD3*, Carol B Benson, MD3,9*, Edmund Cibas, MD10,11*, Sarah P. Hammond, MD3,12*, Nicolas C Issa, MD1,3,13*, Jessica S. Little, MD3,14,15*, Corey S. Cutler, MD, MPH11, Vincent T. Ho, MD11,16*, John Koreth, MD, MBBS, PhD, DPhil11,17, Mahasweta Gooptu, MD11,18, Roman M. Shapiro, MD11,17, Rizwan Romee, MD11,17, Sarah Nikiforow, MD, PhD11,17, Joseph H. Antin, MD11,16, Robert J. Soiffer, MD11,16, C. Sabrina Tan, MD3,19,20*, Sophia Koo, MD, SM3,6,21*, Francisco M. Marty, MD, SM1,3,6*, Lindsey R. Baden, MD3,6,16*, Jerome Ritz, MD11,16 and Matthew P. Cheng, MD, SM22,23,24*

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
2Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA
3Harvard Medical School, Boston
4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
5Rutgers Robert Wood Johnson Medical School, Piscataway, NJ
6Division of Infectious Diseases, Brigham and Women's Hospital, Boston
7Department of Pharmacy Practice, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
8Field Sales, CSL Seqirus Pharmaceuticals, Boston
9Department of Radiology, Brigham and Women's Hospital, Boston
10Department of Pathology, Brigham and Women's Hospital, Boston
11Harvard Medical School, Boston, MA
12Division of Infectious Diseases and Hematology Oncology, Massachusetts General Hospital, Boston
13Division of Infectious Diseases, Brigham & Women's Hospital, Boston, MA
14Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA
15Department of Medical Oncology, Dana-Farber Center Institute, Boston, MA
16Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
17Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
18Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
19Department of Medicine, Beth Israel Deaconess Medical Center, Boston
20Department of Medicine, Carver College of Medicine, iowa city
21Dana-Farber Cancer Institute, Department of Medical Oncology, Boston
22Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Quebec, Canada
23McGill Interdisciplinary Initiative in Infection and Immunity, McGill University, Quebec, Canada
24Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Canada

Scott R. Solomon, MD, Melissa Sanacore, PharmD*, Asad Bashey, MD, PhD, Katelin C Jackson*, Lizamarie Bachier Rodriguez, MD, Lawrence E Morris, MD, H. Kent Holland, MD* and Melhem M. Solh, MD

Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA

Eman Elsabbagh, MD, MSc1 and Henry Foote, MD2*

1Pediatric Transplant and Cellular Therapy, Duke University- School of Medicine, Durham, NC
2Pediatrics, Duke University- School of Medicine, Durham, NC

Sibgha Gull Chaudhary, MD1,2,3*, Moazzam Shahzad, MD1,4, Amir Kasaeian1,3*, Muhammad Fareed Khalid, MD1,3*, Muhammad Kashif Amin, MD1,2,3*, Naghmeh Khavandgar1,3*, Hediyeh Alemi1,3*, Matthew McGuirk1,3*, Kayla Pfannenstiell3*, Syed Nasir Abbas Bukhari1,3*, Sunil Abhyankar, MD1,2,3, Mehdi Hamadani, MD1,5, Joseph P. McGuirk, DO1,2,3 and Muhammad Umair Mushtaq1,2,3

1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
5Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Aijie Huang, MD1*, Guangyu Sun2*, Baolin Tang1*, Yongsheng Han1*, Xiang Wan1*, Wen Yao1*, Kaidi Song1*, Yaxin Cheng1*, Meijuan Tu2*, Bingbing Yan1*, Tianzhong Pan2*, Yue Wu1*, Dongyao Wang, PhD1* and Xiaoyu Zhu1

1Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
2Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China

Moazzam Shahzad, MD1, Zobia Farooq2,3*, Ahmad Sadiq, MD2,3*, Abhinav Vyas, MD2,3, Maham Zaman2,3*, Fatima Khaliq, MBBS2,3*, Rimsha Riaz2,3*, Fatima Inam, MBBS2,3*, Sibgha Gull Chaudhary, MD2,3,4*, Muhammad Kashif Amin, MD2,3,4*, Maggie Nelson, PharmD2,3,4*, Haitham Abdelhakim, MD3,5, Joseph P. McGuirk, DO2,3,4 and Muhammad Umair Mushtaq2,3,4

1Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
4US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS

Valentin Letailleur, MD1*, Maxime Jullien, MD2*, Amandine Le Bourgeois, MD3*, Alice Garnier, MD4*, Pierre Peterlin5*, Sophie Vantyghem, MD3*, Aude-Marie Fourmont, MD3*, Thierry Guillaume, MD, PhD3* and Patrice Chevallier, MD, PhD2

1Hematology Department, CHU Nantes, Nantes, France
2Hematology Department, Nantes University Hospital, Nantes, France
3Hematology Clinic, Nantes University Hospital, Nantes, France
4CHU Nantes Hôpital Hôtel Dieu Hématologie Clinique, Nantes, France
5Hematology Department, Hôtel-Dieu University Hospital, NANTES CEDEX 1, France

Ruirui Gui1*, Zhen Li1*, Juan Wang1*, Yingling Zu1*, Wenli Zhang1*, Xudong Li2*, Wei Li2*, Wenyi Lu3, Chao Li4*, Xianjing Wang5* and Jian Zhou, MD, PhD6*

1Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, zhengzhou, China
2Department of Hematology, The First Affiliated Hospital of Zhengzhou University, zhengzhou, China
3Department of Hematology, Henan Provincial People's Hospital, zhengzhou, China
4nanyang central hospital, nanyang, China
5Department of Hematology, The Third People's Hospital of Zhengzhou, Zhengzhou, China
6Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China

Shunsuke Nishino, MD1*, Hisashi Yamamoto, MD, PhD2*, Mika Kuno, MD2*, Otoya Watanabe, MD2*, Kyosuke Yamaguchi, MD3*, Kosei Kageyama, MD3*, Daisuke Kaji, MD, PhD2*, Yuki Taya, MD, PhD2*, Aya Nishida, MD2*, Shinsuke Takagi, MD, PhD2*, Kazuya Ishiwata, MD3*, Go Yamamoto, MD, PhD2*, Yuki Asano-Mori, MD4, Atsushi Wake, MD, PhD3 and Naoyuki Uchida2

1Department of Hematology, Toranomon Hospital, Minato-Ku, Japan
2Department of Hematology, Toranomon Hospital, Tokyo, Japan
3Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan
4Department of Transfusion and Cell Therapy, Toranomon Hospital, Tokyo, Japan

Michelle L Schoettler, MD1*, Jayre Jones2*, William Briones, BS3*, Elyse Bryson, PA4*, Muna Qayed, MD5, Seema R Patel, PhD6, Katherine Silvis7*, Adrianna Westbrook8*, Kirsten M. Williams, MD9 and Satheesh Chonat, MD10

1Emory University, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
2Emory University School of Medicine, Atlanta, GA
3Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
4Children's Healthcare of Atlanta, Atlanta, GA
5Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
6Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA
7Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and, Atlanta, GA
8Emory University Hospital, Atlanta, GA
9Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
10Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University Department of Pediatrics, Atlanta, GA

Maria Queralt Salas, MD1*, Julia Martinez-Sanchez, PhD2*, Raquel Salinas González, MD3*, Blanca de Moner4*, ANA Belen MORENO Castaño, MD5*, Silvia Escribano-Serrat, MD5*, Alex Ramos6*, Carla Mestre7*, Cristina Padilla8*, Laia Guardia9*, Filipe Pinto, MD9*, Paola Charry, MD10*, Joan Cid, MD PhD11*, Miquel Lozano, MD, PhD12*, Enric Cascos, MD13*, Jordi Esteve, MD, PhD14, Sara Laxe, MD15*, Concepción Closa, MD15*, Enric Carreras, MD, PhD16*, Maria Suarez-Lledo, MD, PhD17*, Laura Rosiñol Dachs, MD PhD18*, Francesc Fernández-Avilés, MD, PhD19*, Montserrat Rovira, MD, PhD19*, Maria Carmen Martinez Munoz, MD, PhD20* and Maribel Diaz-Ricart, PhD2*

1Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
2Hemostasis and Erythropathology, Hematopathology, Pathology Department, CDB, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain
3Physical Medicine and Rehabilitation Department, Hospital Clinic de Barcelona, Barcelona, Spain
4Hospital Clinic de Barcelona, Ba, Spain
5Hospital Clinic Barcelona, Barcelona, Spain
6Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS. Hospital Clinic de Barcelona, Barcelona, Spain
7Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Barcelona, Spain
8Hospital Clinic of Barcelona, Barcelona, ESP
9Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clinic de Barcelona, Barcelona, Spain
10Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clinic de Barcelona, Barcelona, Spain
11Hospital Clinic, University of Barcelona, Barcelona, Spain
12Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
13Cardiology Department, Hospital Clinic de Barcelona, Barcelona, Spain
14Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
15Physical Medicine and Rehabilitation Department, Hospital Clinic of Barcelona, Barcelona, Spain
16Fundació Josep Carreras Contra la Leucèmia, Barcelona, Spain
17Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Spain, Hospital Clínic de Barcelona, Barcelona, Spain
18Hematopoietic Cell Transplant Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
19Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
20Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain

Fan Lin1*, Lanping Xu2*, Zhengli Xu, MD1*, Ting-Ting Han, MD1*, Yun He3*, Yuan-Yuan Zhang, MD1*, Yi-Fei Cheng4*, Xiao-Dong Mo, MD3*, Jingzhi Wang5*, Yu Wang6*, Xiaohui Zhang3 and Xiaojun Huang7

1Peking University People's Hospital, Beijing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
3Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
4Peking University People’s hospital, Beijing, China
5Peking University People’s Hospital, Peking University Institute of Haematology, Collaborative Innovation Center of Haematology, Peking University ,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
6Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
7Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Hang Zhang, MD1*, Hui Liu, MD2*, Ting Liu3, Ting Niu, MD, PhD4, Zhigang Liu, MD, PhD5* and Jie Ji, MD, PhD6*

1Department of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China
2Department of Hematology, People's Hospital of Guangan City, Guangan, China
3Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
4West China Hospital, Sichuan University, Chengdu, China
5Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
6Department of Hematology and Institute of Hematology, Department of Hematology, West China Hospital of Sichuan University, Chengdu, China

Krischan Braitsch, MD1*, Vanessa Nehrbaß1*, Katharina Nickel, MD1*, Maike Hefter, MD1*, Katrin Koch, MD1*, Kathrin Rothe, MD2*, Florian Bassermann, MD1,3,4*, Jochen Schneider, MD5*, Katharina S. Götze, MD1,3,4, Peter Herhaus, MD1* and Mareike Verbeek, MD1*

1Department of Medicine III, Hematology and Oncology, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
2Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany
3German Cancer Consortium (DKTK), partner site Munich, Heidelberg, Germany
4Bavarian Center for Cancer Research (BZKF), Munich, Germany
5Department of Internal Medicine II, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany

Samer A. Srour, MD, Rima M. Saliba, PhD*, Jeremy Ramdial, MD, Portia Smallbone, MD*, Jin S. Im, MD, PhD, Amanda L. Olson, MD, Crystal Carmicheal Kusy*, Betul Oran, MD, MS, George Chen, MD, Muzaffar H. Qazilbash, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Issa F. Khouri, MD, Amin M. Alousi, MD*, Qaiser Bashir, MD, David Marin, MD, Yago Nieto, MD, PhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD and Uday Popat, MD

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH